Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
Department of Health and Human Services
Through this Notice of Funding Opportunity (NOFO) is to accelerate the pace of translation of NCI-supported methods/assays/technologies (referred to as "assays") to the clinic. Specifically, the focus of this NOFO is on the adaption and clinical validation of molecular/cellular/imaging markers (referred to as "markers" r "biomarkers") for cancer detection, diagnosis, prognosis, monitoring, and prediction of response in treatment, as well as markers for cancer control and prevention. Research applications may support the acquisition of well-annotated specimens from NCI-supported or other clinical trials or observational cohorts/consortia for the purpose of clinical validation of the assay. Re
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Next 90 days
Posted
10/10/2024
Closes
2026-10-14
Eligibility
Eligibility
Others (see text field entitled "Additional Information on Eligibility" for clarification)Native American tribal governments (Federally recognized)Small businessesNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationCity or township governmentsSpecial district governmentsIndependent school districtsNative American tribal organizations (other than Federally recognized tribal governments)For profit organizations other than small businessesNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationPublic housing authorities/Indian housing authoritiesState governmentsPrivate institutions of higher educationCounty governmentsPublic and State controlled institutions of higher education
Program
Funding area
Education - EDHealth - HL
Opportunity #
PAR-24-304
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov